about
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain studyTDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD.Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.Defining imaging biomarker cut points for brain aging and Alzheimer's disease.Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults.18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.A biomarker study in long-lasting amnestic mild cognitive impairment.Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
P2860
Q30366283-2EF4F736-4133-439D-9863-B578CA234180Q38382398-D981B17C-C3A7-433F-A0F3-18C6DB000590Q38683683-199D1049-C68D-443D-8C51-2141337AEC45Q38803637-0CCBBBE4-80CF-4309-8279-E80157179D3EQ38812890-B268656B-91F1-4607-A655-E6749FE48DD8Q38893744-77D8CC39-F730-4AAA-B2A1-EB03577F39CDQ47123978-C417FA11-95E6-493C-8531-852758EB1CDCQ47127718-2551CC48-0261-40D6-A391-6AEADC8EECADQ47209544-5A659C19-658C-46BE-ACC7-87B559A7D119Q47587631-464CCB4D-C76F-4954-A538-4BBB0CCCEE45Q47641780-C732FF29-4BD7-4CDC-BBD9-090C265C0323Q47980580-EB8B0F0B-473D-4347-AC8B-4BA057BB0312Q48710914-FA65FF34-DB3C-4C03-A9EB-7F497F444855Q50321758-272F8725-5988-4D87-BFA0-716A5EAEE0E2Q52589491-B8C15423-92AF-4561-966D-E944174A463BQ55223782-C1402A62-BB04-4EB4-8372-2A37CABFB579Q57787592-A869923E-A1A2-4A1F-B27D-5A105C0D0BEF
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Suspected non-AD pathology in mild cognitive impairment
@ast
Suspected non-AD pathology in mild cognitive impairment
@en
type
label
Suspected non-AD pathology in mild cognitive impairment
@ast
Suspected non-AD pathology in mild cognitive impairment
@en
prefLabel
Suspected non-AD pathology in mild cognitive impairment
@ast
Suspected non-AD pathology in mild cognitive impairment
@en
P2093
P2860
P50
P1476
Suspected non-AD pathology in mild cognitive impairment
@en
P2093
Bradford C Dickerson
David A Wolk
Laura E M Wisse
Nirali Butala
Sandhitsu R Das
Sanjeev N Vaishnavi
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2015.08.029
P577
2015-09-07T00:00:00Z